Dai-ichi Life Insurance Company’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44M | Sell |
101,583
-24,914
| -20% | -$7.56M | 1.03% | 19 |
|
|
2026
Q1 | $27M | Buy |
126,497
+1,917
| +2% | +$429K | 0.77% | 24 |
|
|
2025
Q4 | $21.3M | Buy |
124,580
+57,737
| +86% | +$8.98M | 0.55% | 41 |
|
|
2025
Q3 | $8.95M | Buy |
66,843
+8,000
| +14% | +$847K | 0.22% | 94 |
|
|
2025
Q2 | $5.73M | Sell |
58,843
-8,754
| -13% | -$694K | 0.16% | 138 |
|
|
2025
Q1 | $4.91M | Hold |
67,597
| – | – | 0.14% | 154 |
|
|
2024
Q4 | $4.88M | Sell |
67,597
-19,013
| -22% | -$1.44M | 0.14% | 160 |
|
|
2024
Q3 | $7.07M | Sell |
86,610
-30,090
| -26% | -$2.62M | 0.18% | 120 |
|
|
2024
Q2 | $12.4M | Sell |
116,700
-30,950
| -21% | -$2.97M | 0.3% | 84 |
|
|
2024
Q1 | $14.3M | Sell |
147,650
-2,270
| -2% | -$200K | 0.32% | 72 |
|
|
2023
Q4 | $11.7M | Buy |
149,920
+56,180
| +60% | +$3.83M | 0.24% | 94 |
|
|
2023
Q3 | $5.88M | Hold |
93,740
| – | – | 0.13% | 150 |
|
|
2023
Q2 | $6.03M | Sell |
93,740
-40,800
| -30% | -$2.3M | 0.13% | 149 |
|
|
2023
Q1 | $7.13M | Hold |
134,540
| – | – | 0.16% | 127 |
|
|
2022
Q4 | $5.65M | Sell |
134,540
-15,000
| -10% | -$627K | 0.13% | 156 |
|
|
2022
Q3 | $5.47M | Hold |
149,540
| – | – | 0.13% | 145 |
|
|
2022
Q2 | $6.37M | Sell |
149,540
-20,000
| -12% | -$952K | 0.14% | 135 |
|
|
2022
Q1 | $9.12M | Sell |
169,540
-25,000
| -13% | -$1.46M | 0.15% | 140 |
|
|
2021
Q4 | $14M | Sell |
194,540
-30,000
| -13% | -$1.88M | 0.18% | 110 |
|
|
2021
Q3 | $12.8M | Sell |
224,540
-17,480
| -7% | -$1.06M | 0.17% | 115 |
|
|
2021
Q2 | $15.7M | Buy |
242,020
+32,850
| +16% | +$2.07M | 0.2% | 95 |
|
|
2021
Q1 | $12.5M | Buy |
209,170
+21,900
| +12% | +$1.19M | 0.17% | 100 |
|
|
2020
Q4 | $8.84M | Buy |
187,270
+43,370
| +30% | +$1.82M | 0.13% | 133 |
|
|
2020
Q3 | $4.77M | Sell |
143,900
-2,060
| -1% | -$71K | 0.09% | 175 |
|
|
2020
Q2 | $4.72M | Sell |
145,960
-72,320
| -33% | -$1.97M | 0.11% | 148 |
|
|
2020
Q1 | $5.24M | Sell |
218,280
-133,560
| -38% | -$3.85M | 0.2% | 119 |
|
|
2019
Q4 | $10.3M | Sell |
351,840
-22,530
| -6% | -$598K | 0.23% | 98 |
|
|
2019
Q3 | $8.65M | Buy |
374,370
+253,990
| +211% | +$5.33M | 0.21% | 109 |
|
|
2019
Q2 | $2.26M | Hold |
120,380
| – | – | 0.05% | 313 |
|
|
2019
Q1 | $2.15M | Buy |
120,380
+100,000
| +491% | +$1.67M | 0.05% | 325 |
|
|
2018
Q4 | $278K | Hold |
20,380
| – | – | 0.01% | 453 |
|
|
2018
Q3 | $309K | Hold |
20,380
| – | – | 0.01% | 465 |
|
|
2018
Q2 | $352K | Sell |
20,380
-272,720
| -93% | -$5.25M | 0.01% | 456 |
|
|
2018
Q1 | $5.96M | Sell |
293,100
-50,000
| -15% | -$990K | 0.12% | 164 |
|
|
2017
Q4 | $6.32M | Buy |
343,100
+32,310
| +10% | +$635K | 0.12% | 162 |
|
|
2017
Q3 | $5.75M | Sell |
310,790
-241,690
| -44% | -$3.92M | 0.12% | 168 |
|
|
2017
Q2 | $7.81M | Buy |
552,480
+30,290
| +6% | +$444K | 0.17% | 127 |
|
|
2017
Q1 | $6.7M | Sell |
522,190
-195,820
| -27% | -$2.3M | 0.18% | 139 |
|
|
2016
Q4 | $7.59M | Buy |
+718,010
| New | +$7.29M | 0.22% | 115 |
|
Other funds holding LRCX
Dai-ichi Life Insurance Company's LRCX Position: Q2 2026 in Review
Dai-ichi Life Insurance Company reduced its Lam Research (LRCX) stake by 20% in Q2 2026, selling an estimated $7.56M and leaving 101,583 shares worth $44M. The position accounts for 1.03% of the portfolio, ranked #19.
Dai-ichi Life Insurance Company first reported a position in LRCX in Q4 2016 and has held it in 39 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Dai-ichi Life Insurance Company held 101,583 shares of Lam Research worth $44M as of Q2 2026.
- Dai-ichi Life Insurance Company sold 24,914 Lam Research shares in Q2 2026, an estimated $7.56M.
- Lam Research made up 1.03% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #19 holding.
- Dai-ichi Life Insurance Company first reported a position in Lam Research in Q4 2016 and has held it in 39 quarters since.
- 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.